Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From the 10Q - subsequent events
Reply New Message
Prev Message Back To Forum Threaded View Next Message
With 500MM authorized common shares and 420MM common shares outstanding (fully diluted), the company only has 80MM shares to work with. At the current share price, that's only $62.5MM. Can't buy much with that, IMO. They have another 5MM preferred shares authorized and available, but that doesn't add much to the pot.
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply